Harbin Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 6,405.785 million compared to CNY 4,809.380 million a year ago. Operating income was CNY 461.913 million compared to operating loss of CNY 262.619 million a year ago. Net income was CNY 342.088 million compared to net loss of CNY 333.302 million a year ago. Basic earnings per share from continuing operations was CNY 0.14 compared to basic loss per share from continuing operations of CNY 0.13 a year ago.